With the XYTOS mission to introduce Next Generation Advanced Bio-Medical Technologies in the areas of Stem Cell Therapy, Tissue Engineering, Cellular Medicine and Cancer; and the ultimate goal to enhance the quality of life for our patients, we at XYTOS have concentrated on our research and development for the past several years.

With the success that we have now achieved in our Bio-Medical Technologies, we have now turned our attention to aggressively moving XYTOS International, Inc. to the Frankfurt Stock Exchange under the Stock Symbol (XY5.F). The is the next step in establishing a Global presence for XYTOS International, Inc.